Omega Healthcare Investors Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Omega Healthcare Investors wird ein jährliches Gewinn- und Umsatzwachstum von 9.6% bzw. 0.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.5% betragen.
Wichtige Informationen
9.6%
Wachstumsrate der Gewinne
6.8%
EPS-Wachstumsrate
| Health Care REITs Gewinnwachstum | 22.9% |
| Wachstumsrate der Einnahmen | 0.1% |
| Zukünftige Eigenkapitalrendite | 11.5% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Omega Healthcare Investors: Not An Alpha Generating Stock
Oct 05Omega Healthcare Investors: High Dividend Yield And An Expected Massive Market
Sep 12Omega Healthcare: Attractive 7% Yield + 3 Other High Yield REITs
Aug 05Omega Healthcare Investors: 8.4% Yield And Selling Below Fair Price
Jun 14Omega Healthcare: You May Want To Wait For A Better Price
Jun 03Omega Healthcare: Clarity Regarding The Dividend Makes This 8.75% REIT Interesting
May 21Omega Healthcare: Better Options In The Healthcare Space For Dividend Investors
Apr 13Omega Healthcare Investors: How Safe Is The 9% Yield
Mar 28Omega Healthcare: Mr. Market Liked 2024 Guidance As The 8.55% Yield Remains Intact
Feb 26Omega Healthcare: This 9% Yield Is Not Safe
Jan 23Omega Healthcare Has Retraced As REITs Rallied Pushing The Yield To 8.71%
Dec 22Omega Healthcare Investors: Re-Adding This 8.4% Yielding Healthcare REIT On The Dip
Nov 29Omega Healthcare: High Yield 8+% Stock That Keeps On Paying
Nov 14Omega Healthcare: Time To Stop Adding This Passive Income Generator (Downgrade)
Oct 09Should You Buy Omega Healthcare Investors For Its 8.5% Yield?
Sep 08Omega Healthcare: The Power Of A Well-Covered High-Yield
Aug 15Omega Healthcare Has Been Heating Up, And The Dividend Keep Coming
Jul 18Omega Healthcare: Why The Stock Is A Hold
Jun 149.4%-Yielding Omega Healthcare: A Bargain With Upside Potential
May 25Omega Healthcare Investors FFO of $0.73 beats by $0.02, revenue of $144.85M misses by $25.77M
Feb 02Omega Healthcare Investors declares $0.67 dividend
Jan 26Omega Healthcare Investors sees EBITDA, funds available for distribution declining in Q1
Jan 09Omega Healthcare: Buy The Drop On This 10% Yield
Jan 01Omega Healthcare Q3: 8% Yielding Dividend Machine Provided Positive Guidance For Income Investors
Nov 14Omega Healthcare Investors declares $0.67 dividend
Oct 219%-Yielding Omega Healthcare Is Too Good To Pass Up
Oct 14Realty Income Shares Have Gone Nowhere For 6 Plus Years
Sep 28Omega Healthcare: Financial Strength Of Tenants Improved And Aging Demographics Are Positive
Sep 13Omega Healthcare: 8.2% Yield, Good Coverage, Low Valuation
Aug 24Omega Healthcare Q2 And Our Patience Test
Aug 11What's in store for Omega Healthcare Investors Q2 Earnings?
Jul 29Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 955 | 489 | 893 | N/A | 7 |
| 12/31/2025 | 919 | 446 | 858 | N/A | 9 |
| 12/31/2024 | 851 | 408 | 835 | N/A | 9 |
| 9/30/2024 | 1,011 | 348 | 685 | 685 | N/A |
| 6/30/2024 | 977 | 328 | 672 | 672 | N/A |
| 3/31/2024 | 975 | 274 | 658 | 658 | N/A |
| 12/31/2023 | 950 | 242 | 618 | 618 | N/A |
| 9/30/2023 | 855 | 233 | 606 | 606 | N/A |
| 6/30/2023 | 853 | 244 | 602 | 602 | N/A |
| 3/31/2023 | 847 | 273 | 605 | 605 | N/A |
| 12/31/2022 | 878 | 427 | 626 | 626 | N/A |
| 9/30/2022 | 983 | 415 | 629 | 629 | N/A |
| 6/30/2022 | 1,026 | 451 | 649 | 649 | N/A |
| 3/31/2022 | 1,038 | 446 | 678 | 678 | N/A |
| 12/31/2021 | 1,063 | 417 | 722 | 722 | N/A |
| 9/30/2021 | 1,077 | 445 | 763 | 763 | N/A |
| 6/30/2021 | 914 | 215 | 757 | 757 | N/A |
| 3/31/2021 | 913 | 229 | 745 | 745 | N/A |
| 12/31/2020 | 892 | 159 | 708 | 708 | N/A |
| 9/30/2020 | 875 | 157 | 659 | 659 | N/A |
| 6/30/2020 | 989 | 388 | 618 | 618 | N/A |
| 3/31/2020 | 958 | 361 | 583 | 583 | N/A |
| 12/31/2019 | 929 | 341 | 554 | 554 | N/A |
| 9/30/2019 | 902 | 344 | 557 | 557 | N/A |
| 6/30/2019 | 891 | 262 | 548 | 548 | N/A |
| 3/31/2019 | 885 | 267 | 557 | 557 | N/A |
| 12/31/2018 | 882 | 282 | 499 | 499 | N/A |
| 9/30/2018 | 883 | 282 | 499 | 499 | N/A |
| 6/30/2018 | 881 | 93 | N/A | 531 | N/A |
| 3/31/2018 | 897 | 80 | N/A | 518 | N/A |
| 12/31/2017 | 908 | 100 | N/A | 578 | N/A |
| 9/30/2017 | 922 | 162 | N/A | 595 | N/A |
| 6/30/2017 | 927 | 373 | N/A | 602 | N/A |
| 3/31/2017 | 920 | 415 | N/A | 610 | N/A |
| 12/31/2016 | 901 | 366 | N/A | 625 | N/A |
| 9/30/2016 | 877 | 303 | N/A | 598 | N/A |
| 6/30/2016 | 854 | 304 | N/A | 558 | N/A |
| 3/31/2016 | 823 | 237 | N/A | 488 | N/A |
| 12/31/2015 | 744 | 225 | N/A | 449 | N/A |
| 9/30/2015 | 664 | 221 | N/A | 401 | N/A |
| 6/30/2015 | 593 | 203 | N/A | 364 | N/A |
| 3/31/2015 | 517 | 209 | N/A | 363 | N/A |
| 12/31/2014 | 505 | 221 | N/A | 338 | N/A |
| 9/30/2014 | 485 | 212 | N/A | 339 | N/A |
| 6/30/2014 | 457 | 188 | N/A | 325 | N/A |
| 3/31/2014 | 438 | 190 | N/A | 300 | N/A |
| 12/31/2013 | 419 | 173 | N/A | 280 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: OHIDas prognostizierte Gewinnwachstum (9.6% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: OHIDie Erträge des Unternehmens (9.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: OHIDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: OHIDie Einnahmen des Unternehmens (0.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: OHIDie Einnahmen des Unternehmens (0.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: OHIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.5%).